Literature DB >> 31605800

Using R and Bioconductor in Clinical Genomics and Transcriptomics.

Jorge L Sepulveda1.   

Abstract

Bioinformatics pipelines are essential in the analysis of genomic and transcriptomic data generated by next-generation sequencing (NGS). Recent guidelines emphasize the need for rigorous validation and assessment of robustness, reproducibility, and quality of NGS analytic pipelines intended for clinical use. Software tools written in the R statistical language and, in particular, the set of tools available in the Bioconductor repository are widely used in research bioinformatics; and these frameworks offer several advantages for use in clinical bioinformatics, including the breath of available tools, modular nature of software packages, ease of installation, enforcement of interoperability, version control, and short learning curve. This review provides an introduction to R and Bioconductor software, its advantages and limitations for clinical bioinformatics, and illustrative examples of tools that can be used in various steps of NGS analysis.
Copyright © 2020 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31605800     DOI: 10.1016/j.jmoldx.2019.08.006

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  19 in total

1.  Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer.

Authors:  Juntao Wang; Junde Zhao; Zhiheng Lin; Weisen Fan; Xiaohui Sui
Journal:  Reprod Sci       Date:  2022-07-19       Impact factor: 2.924

2.  Identification of Immune-Related Gene Signature in Stanford Type A Aortic Dissection.

Authors:  Zhaoshui Li; Jumiao Wang; Qiao Yu; Ruxin Shen; Kun Qin; Yu Zhang; Youjin Qiao; Yifan Chi
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

3.  Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods.

Authors:  Siyu Guo; Jiarui Wu; Wei Zhou; Xinkui Liu; Yingying Liu; Jingyuan Zhang; Shanshan Jia; Jialin Li; Haojia Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

4.  Multi-Staged Data-Integrated Multi-Omics Analysis for Symptom Science Research.

Authors:  Carolyn S Harris; Christine A Miaskowski; Anand A Dhruva; Janine Cataldo; Kord M Kober
Journal:  Biol Res Nurs       Date:  2021-04-08       Impact factor: 2.318

5.  Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.

Authors:  Shuoling Chen; Chang Gao; Yangyuan Wu; Zunnan Huang
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

6.  Long Non-Coding RNA Signatures Associated with Ferroptosis Predict Prognosis in Colorectal Cancer.

Authors:  Na Li; Jiangli Shen; Ximin Qiao; Yuan Gao; Hong-Bo Su; Shuai Zhang
Journal:  Int J Gen Med       Date:  2022-01-04

7.  Construction of the Classification Model Using Key Genes Identified Between Benign and Malignant Thyroid Nodules From Comprehensive Transcriptomic Data.

Authors:  Qingxia Yang; Yaguo Gong
Journal:  Front Genet       Date:  2022-01-14       Impact factor: 4.599

8.  Biological Function and Clinical Value of VPS13A in Pan-Cancer Based on Bioinformatics Analysis.

Authors:  Xue Qin Zhang; Li Li
Journal:  Int J Gen Med       Date:  2021-10-16

9.  Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.

Authors:  Wei Ma; Manli Zhong; Xiaowu Liu
Journal:  Biosci Rep       Date:  2021-08-27       Impact factor: 3.840

10.  Detection of H3K4me3 Identifies NeuroHIV Signatures, Genomic Effects of Methamphetamine and Addiction Pathways in Postmortem HIV+ Brain Specimens that Are Not Amenable to Transcriptome Analysis.

Authors:  Liana Basova; Alexander Lindsey; Anne Marie McGovern; Ronald J Ellis; Maria Cecilia Garibaldi Marcondes
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.